NRBO
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapies for viral, neuropathic and neurodegenerative diseases. The company’s current pipeline consists of three therapeutic programs targeting COVID-19, pain indications and Alzheimer’s disease.
Mar 27
Looks like NeuroBo Pharmaceuticals Inc doesn't offer shareholder perks yet... tell NeuroBo Pharmaceuticals Inc (Tii:NRBO) you want perks by adding your email below.
TiiCKER offers a completely personalized experience and first-ever way to view your stock portfolio, trade for free and invest in new companies while viewing your perks in one place!
Create a profile
Connect accounts
Discover brands
Collect rewards
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapies for viral, neuropathic and neurodegenerative diseases. The company’s current pipeline consists of three therapeutic programs targeting COVID-19, pain indications and Alzheimer’s disease.
RICHARD J. KANG
Boston, MA
2014
12
TiiCKER was created for fan-first, brand-first public companies—with exclusive perks served-up weekly to shareholders. Own stock? Connect your brokerage account to view more than 130 perks waiting for you right now!